Memphis Pharmaceuticals (MPCI.CA) Reports 9 Months Results
|
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010 Currency : EGP F/S Period : From 01/07/2021 to 31/03/2022 Net Profit : 20,997,118 F/S Period: From 01/07/2020 to 31/03/2021 Net Comparative Profit : 25,372,835 Audit Status : Reviewed Source : Memphis Pharmaceuticals |
Comments